After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Mirum Pharmaceuticals Inc is $3.27B. A total of 1.11 million shares were traded on the day, compared to an average of 468.90K shares.
In the most recent transaction, Peetz Christopher sold 40,000 shares of MIRM for 62.00 per share on Aug 11 ’25. After the transaction, the CHIEF EXECUTIVE OFFICER now owns 138,641 company shares. In a previous transaction on Aug 11 ’25, CHRISTOPHER PEETZ bought 40,000 shares at 62.00 per share.
Among the insiders who sold shares, Howe Jolanda disposed of 10,000 shares on Aug 07 ’25 at a per-share price of $58.00. This resulted in the SVP, GLOBAL CONTROLLER holding 2,426 shares of MIRM after the transaction. In another insider transaction, Peetz Christopher sold 40,000 shares at $55.25 per share on Aug 07 ’25. Company shares held by the CHIEF EXECUTIVE OFFICER now total 138,641.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MIRM has a high of $67.45 and a low of $36.86.
As of this writing, MIRM has an earnings estimate of -$0.19 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.03 per share and a lower estimate of -$0.33. The company reported an EPS of -$0.3 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MIRM’s latest balance sheet shows that the firm has $156.54M in Cash & Short Term Investments as of fiscal 2021. There were $2.61M in debt and $42.60M in liabilities at the time. Its Book Value Per Share was $5.10, while its Total Shareholder’s Equity was $120.21M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MIRM is Buy with a score of 5.00.
